Abstracts and full text articles are now available online immediately
after publication.
Note:
This index can be searched by subject using your Browsers Find
function. Author(s) Year; Volume (Issue): Page.
Use the Find button if you are using Netscape, or use the Edit
(pulldown menu) and Find (on this page) in Internet Explorer.
© 2004 The Australasian
Association of Clinical Biochemists

Vol 30,
2009
Editorial
Jill Tate, Peter Mollee, Roger Johnson
2009:30(iii):89
View
Full Text (pdf)
List of Abbreviations
2009:30(iii):92
View
Full Text (pdf)
Current Trends in
the Diagnosis, Therapy and Monitoring
of the Monoclonal Gammopathies
Peter Mollee
2009:30(iii):93
Abstract
View
Full Text (pdf)
Screening Panels for
Monoclonal Gammopathies: Time to Change
Jerry A Katzmann
2009:30(iii):105
Abstract
View
Full Text (pdf)
Significance of Abnormal
Protein Bands in Patients with Multiple
Myeloma following Autologous Stem Cell Transplantation
Sara L. Hall, Jill Tate,Devinder Gill,Peter Mollee
2009:30(iii):113
Abstract
View
Full Text (pdf)
Serum and Urine Electrophoresis
for Detection and Identification of
Monoclonal Proteins
Margaret A. Jenkins
2009:30(iii):119
Abstract
View
Full Text (pdf)
Isoelectric Focusing,
Blotting and Probing Methods for Detection and
Identification of Monoclonal Proteins
Findley N Cornell
2009:30(iii):123
Abstract
View
Full Text (pdf)
Quantitative Serum
Free Light Chain Assay – Analytical Issues
Jill Tate, Sheree Bazeley, Stephen Sykes, Peter Mollee
2009:30(iii):131
Abstract
View
Full Text (pdf)
Reporting of Quantitative
Protein Electrophoresis in Australia and
New Zealand: a Call for Standardisation
Zoe Inman, Helen Martin, SA Paul Chubb
2009:30(iii):141
Abstract
View
Full Text (pdf)
The Stewart Approach
– One Clinician’s Perspective
T John Morgan
2009:30(ii):41
Abstract
View
Full Text (pdf)
Clinical Use of Pharmacogenomic
Tests in 2009
Leslie J Sheffield, Hazel E Phillimore
2009:30(ii):55
Abstract
View
Full Text (pdf)
Investigating Maturity
Onset Diabetes of the Young
Ohn Nyunt, Joyce Y Wu, Ivan N McGown, Mark Harris, Tony Huynh, Gary
M Leong, David M Cowley, Andrew M Cotterill
2009:30(ii):67
Abstract
View
Full Text (pdf)
The Clinical and Biochemical
Spectrum of Congenital Adrenal
Hyperplasia Secondary to 21-Hydroxylase Deficiency
Tony Huynh, Ivan McGown, David Cowley, Ohn Nyunt, Gary M Leong, Mark
Harris, Andrew M Cotterill
2009:30(ii):75
Abstract
View
Full Text (pdf)
Advances in Biochemical
Screening for Phaeochromocytoma using
Biogenic Amines
Malcolm J. Whiting, Matthew P. Doogue
2009:30(i):3
Abstract
View
Full Text (pdf)
Principles and Applications
of Liquid Chromatography-
Mass Spectrometry in Clinical Biochemistry
James J Pitt
2009:30(i):19
Abstract
View
Full Text (pdf)
Hyponatremia Treatment
Guidelines 2007:
Expert Panel Recommendations
SA Paul Chubb
2009:30(i):35
View
Full Text (pdf)
Vol 29, 2008
Closing the Gaps in Paediatric Reference
Intervals:
The CALIPER Initiative
Kareena Schnabl, Man Khun Chan, Yanping Gong,Khosrow Adeli
2008:29(iii):89
Abstract
View
Full Text (pdf)
An Evidence-base for Laboratory Endocrinology?
Julian H Barth
2008:29(iii):97
View
Full Text (pdf)
The Diagnosis of Cushing’s Syndrome:
An Endocrine Society Clinical
Practice Guideline
Rhonda Gilbert,Ee Mun Lim
2008:29(iii):103
View
Full Text (pdf)
National Academy of Clinical Biochemistry
(NACB) Laboratory Medicine
Guidelines on the Clinical Utilization and Analytical Issues for Cardiac
Biomarker Testing in Heart Failure
John Beilby
2008:29(iii):107
View
Full Text (pdf)
Royal College of Pathologists of Australasia
(RCPA) and Australasian
Association of Clinical Biochemists (AACB) Position Statement on
Impaired Fasting Glucose
RCPA and AACB
2008:29(iii):113
View
Full Text (pdf)
Proceedings of the Australasian Association
of Clinical Biochemists’
45th Annual Scientific Conference
2008:29 Supplement (ii) S115
View
Full Text (pdf)
Analytical Quality – What Should We
be Aiming for?
Ken Sikaris
2008:29 Supplement (i):S5
Summary
View
Full Text (pdf)
Pre-Analytical Requirements
John H Livesey, M Jane Ellis, Margaret J Evans
2008:29 Supplement (i):S11
Summary
View
Full Text (pdf)
Selection of a Suitable Assay
Peter G Murphy
2008:29 Supplement (i):S17
Summary
View
Full Text (pdf)
Evaluating Assay Precision
Douglas Chesher
2008:29 Supplement (i):S23
Summary
View
Full Text (pdf)
Use of Capability Index to Improve Laboratory
Analytical Performance
Renze Bais
2008:29 Supplement (i):S27
Summary
View
Full Text (pdf)
Imprecision Profiling
William A Sadler
2008:29 Supplement (i):S33
Summary
View
Full Text (pdf)
Assessment of Bias with Emphasis on Method
Comparison
Roger Johnson
2008:29 Supplement (i):S37
Summary
View
Full Text (pdf)
Interference Testing
Goce Dimeski
2008:29 Supplement (i):S43
Summary
View
Full Text (pdf)
Limit of Blank, Limit of Detection and Limit
of Quantitation
David A Armbruster, Terry Pry
2008:29 Supplement (i):S49
Summary
View
Full Text (pdf)
Basics of Estimating Measurement Uncertainty
Graham H White
2008:29 Supplement (i):S53
Summary
View
Full Text (pdf)
Traceability of Measurement Results
George Koumantakis
2008:29 Supplement (i):S61
Summary
View
Full Text (pdf)
The Quality Control System
Tony Badrick
2008:29 Supplement (i):S67
Summary
View
Full Text (pdf)
Parallel Processing and Maintaining Adequate
Alignment between
Instruments and Methods
John Calleja
2008:29 Supplement (i):S71
Summary
View
Full Text (pdf)
Quality Control Issues in Point of Care
Testing
Cameron L Martin
2008:29 Supplement (i):S79
Summary
View
Full Text (pdf)
Sensitivity, Specificity, Receiver-Operating
Characteristic (ROC) Curves
and Likelihood Ratios: Communicating the Performance of Diagnostic Tests
Christopher M Florkowski
2008:29 Supplement (i):S83
Summary
View
Full Text (pdf)
Significant Figures
Tony Badrick, Peter E Hickman
2008:29 Supplement (i):S89
Summary
View
Full Text (pdf)
Reference Intervals
Graham Jones, Antony Barker
2008:29 Supplement (i):S93
Summary
View
Full Text (pdf)
Interpretative Commenting
Samuel Vasikaran
2008:29 Supplement (i):S99
Summary
View
Full Text (pdf)
Expert Systems for Clinical Pathology Reporting
Glenn A Edwards
2008:29 Supplement (i):S105
Summary
View
Full Text (pdf)
Cystatin C – A Paradigm of Evidence
Based Laboratory Medicine
Janice SC Chew, Mohammed Saleem,Christopher M Florkowski, Peter M George
2008:29(ii):47
Abstract
View
Full Text (pdf)
Low Level Environmental Lead Exposure –
A Continuing Challenge
Enrico Rossi
2008:29(ii):63
Abstract
View
Full Text (pdf)
Coenzyme Q10: Is There a Clinical Role and
a Case for Measurement?
Sarah L Molyneux, Joanna M Young, Christopher M Florkowski, Michael
Lever,
Peter M George
2008:29(ii):71
Abstract
View
Full Text (pdf)
Management of Thyroid Dysfunction during
Pregnancy and Postpartum:
An Endocrine Society Clinical Practice Guideline
Paul Glendenning
2008:29(i):83
View
Full Text (pdf)
The Modernisation of Pathology and Laboratory
Medicine in the UK:
Networking into the Future
Graham H Beastall
2008:29(i):3
View
Full Text (pdf)
Common and Rare Gene Variants Affecting
Plasma LDL Cholesterol
John R Burnett, Amanda J Hooper
2008:29(i):11
Abstract
View
Full Text (pdf)
Homocysteine and Cardiovascular Disease:
Should We Treat?
Kathleen Potter
2008:29(i):27
View
Full Text (pdf)
Phenylketonuria: An Inborn Error of Phenylalanine
Metabolism
Robin A Williams, Cyril DS Mamotte, John R Burnett
2009:29(i):31
Abstract
View
Full Text (pdf)
Vol 28, 2007
Proceedings of the Australasian Association
of Clinical Biochemists’
45th Annual Scientific Conference
2007:27 Supplement (i):S6
View
Full Text (pdf)
Standardisation - The Theory and the Practice
Jill Tate, Mauro Panteghini
2007:28(iv):127
View
Full Text (pdf)
Reference Materials and Reference Measurement
Procedures:
An Overview from a National Metrology Institute
David M Bunk
2007:28(iv):131
Abstract
View
Full Text (pdf)
Reference Materials and Commutability
Hubert W Vesper, W Gregory Miller, Gary L Myers
2007:28(iv):139
Abstract
View
Full Text (pdf)
Requirements for Reference (Calibration)
Laboratories in Laboratory
Medicine
Lothar Siekmann
2007:28(iv):149
Abstract
View
Full Text (pdf)
Traceability in Clinical Enzymology
Ilenia Infusino, Roberto Bonora, Mauro Panteghini
2007:28(iv):155
Abstract
View
Full Text (pdf)
HbA1c Standardisation: History, Science
and Politics
W Garry John, Andrea Mosca, Cas Weykamp, Ian Goodall
2007:28(iv):163
Abstract
View
Full Text (pdf)
Standardisation of Reference Intervals:
An Australasian View
Graham Jones,Antony Barker
2007:28(iv):169
Abstract
View
Full Text (pdf)
EQA from an Australian Perspective
Renze Bais
2007:28(iv):175
Abstract
View
Full Text (pdf)
Laboratory Turnaround Time
Robert C Hawkins
2007:28(iv):179
Abstract
View
Full Text (pdf)
The Changing Role of the Clinical Laboratory
in the Investigation of
Polycystic Ovarian Syndrome
A Michael Wallace, Naveed Sattar
2007:28(iii):79
Abstract
View
Full Text (pdf)
Standardisation - The Theory and the Practice
Jill Tate, Mauro Panteghini
2007:28(iii):93
View
Full Text (pdf)
Traceability, Reference Systems and Result
Comparability
Mauro Panteghini
2007:28(iii):97
Abstract
View
Full Text (pdf)
The Joint Committee for Traceability in
Laboratory Medicine (JCTLM):
A Global Approach to Promote the Standardisation of Clinical
Laboratory Test Results
David Armbruster, Richard R Miller
2007:28(iii):105
Abstract
View
Full Text (pdf)
Prerequisites for Use of Common Reference
Intervals
Ferruccio Ceriotti
2007:28(iii):115
Abstract
View
Full Text (pdf)
Recommendations for Lipid Testing and Reporting
by Australian Pathology Laboratories
Charles A Appleton, Grahame Caldwell, Alan McNeil,
Matthew Meerkin, Ken Sikaris,David R Sullivan, David W Thomas, David
P Tognarini
2007:28(ii):32
Abstract
View
Full Text (pdf)
Rationale for Recommendations for Lipid
Testing and Reporting by Australian Pathology Laboratories
David R Sullivan, David W Thomas, David P Tognarini
2007:28(ii):46
View
Full Text (pdf)
Recommendations for Lipid Testing and Reporting
by Australian Pathology Laboratories: an important development
Graham RD Jones
2007:28(ii):50
View
Full Text (pdf)
DNA: Where to Now?
John Beilby
2007:28(ii):52
View
Full Text (pdf)
The Limitations of Sweat Electrolyte Reference
Intervals for the Diagnosis of Cystic Fibrosis:
A Systematic Review
Avantika Mishra,Ronda Greaves, John Massie
2007:28(ii):60
Abstract
View
Full Text (pdf)
Assessing Liver Fibrosis with Serum Marker
Models
Enrico Rossi, Leon A Adams, Max Bulsara, Gary
P Jeffrey
2007:28(i):3
Abstract
View
Full Text (pdf)
Hepatorenal Syndrome
Charles KF Ng, Michael HM Chan, Morris HL Tai,
Christopher WK Lam
2007:28(i):11
Abstract
View
Full Text (pdf)
New Zealand Cardiovascular Guidelines: Best
Practice Evidence-based Guideline:
The Assessment and Management of Cardiovascular Risk
December 2003
http://www.nzgg.org.nz/guidelines/0035/CVD_Risk_Full.pdf
Michael Crooke
2007:28(i):19
View
Full Text (pdf)

Vol 27, 2006
Measurement of Serum Creatinine – Current Status and Future Goals
Michael Peake, Malcolm Whiting
2006:27(iv):173
Abstract
View
Full Text (pdf)
The Analytical Quality of Point-of-Care Testing in the ‘QAAMS’
Model
for Diabetes Management in Australian Aboriginal Medical Services
Mark DS Shephard, Janice P Gill
2006:27(iv):185
Abstract
View
Full Text (pdf)
Book Review: Fundamental Toxicology
Duffus JH, Worth HGJ, editors. RSC Publishing, Cambridge; 2006
Kenneth F Ilett
2006:27(iv):123
View
Full Text (pdf)
Proceedings of the Australasian Association of Clinical Biochemists’
44th Annual Scientific Conference
2006:27(iv):S11
View
Full Text (pdf)
Editorial:The Role of Biochemical Markers of Bone Turnover in Osteoporosis
Management in Clinical Practice
Samuel D Vasikaran, Paul Glendenning, Howard A
Morris
2006:27(iii):119
View
Full Text (pdf)
Biochemical Markers of Bone Turnover
Part II: Clinical Applications in the Management of Osteoporosis
Markus J Seibel
2006:27(iii):123
Abstract
View
Full Text (pdf)
Steroid Analysis in Saliva: An overview
John G Lewis
2006:27(iii):139
Abstract
View
Full Text (pdf)
Drug Testing in Oral Fluid
Olaf H Drummer
2006:27(iii):147
Abstract
View
Full Text (pdf)
Cultural and Clinical Effectiveness of the ‘QAAMS’
Point-of-Care Testing Model for Diabetes Management
in Australian Aboriginal Medical Services.
Mark DS Shephard
2006:27(iii):161
Abstract
View
Full Text (pdf)
Computerised Order Entry Systems and Pathology Services - A Synthesis
of the Evidence
Andrew Georgiou, Johanna I Westbrook
2006:27(ii):79
Abstract
View
Full Text (pdf)
Communication Systems in Healthcare
Enrico Coiera
2006:27(ii):89
Abstract
View
Full Text (pdf)
Clinical Proteomics: Present and Future Prospects
Nicole M Verrills
2006:27(ii):99
Abstract
View
Full Text (pdf)
Supplement:
Australian Guidelines for the Performance of the Sweat Test
for the Diagnosis of Cystic Fibrosis
Report from the AACB Sweat Testing Working Party
2006:27(ii):S1
Introduction
View
Full Text (pdf)
Diagnostic Molecular Biology (Editorial)
John Beilby
2006:27(i):3
View
Full Text (pdf)
Normal Iron Metabolism and the Pathophysiology
of Iron Overload Disorders
Chiang W Siah, John Ombiga, Leon A Adams, Debbie Trinder, John K Olynk
2006:27(i):5
Abstract
View
Full Text (pdf)
The Influence of Cytochrome P450 Pharmacogenetics
on Disposition of Common Antidepressant and Antipsychotic Medications
Jan der Weide and John WJ Hinrichs
2006:27(i):17
Abstract
View
Full Text (pdf)
Diagnosis of the Haemoglobinopathies
Ronald J Trent
2006:27(i):27
Abstract
View
Full Text (pdf)
Clinical Applications of Molecular Biology for
Infectious Diseases
David J Speers
2006:27(i):39
Abstract
View
Full Text (pdf)
Ethical Considerations in the Use of DNA for
the Diagnosis of Diseases
Kristine Barlow-Stewart amd Leslie Burnett
2006:27(i):53
Abstract
View
Full Text (pdf)
Genotyping of Single Nucleotide Substiutions
Cyril DS Mamotte
2006:27(i):63
Abstract
View
Full Text (pdf)
Vol 26, 2005
Making the Most of a Patient’s
Laboratory Data:
Optimisation of Signal-to-Noise Ratio
Per Hyltoft Petersen
2005;26(iv):91
View Abstract View
Full Text (pdf)
Biochemical Markers of Bone Turnover
Part I : Biochemistry and Variability
Markus J Seibel
2005;26(iv):97
View Abstract
View
Full Text (pdf)
Below the Radar:
Advanced Glycation End Products that Detour “around the side”
Is HbA1c not an accurate enough predictor of long term progression and
glycaemic control in diabetes?
Josephine M Forbes, Georgia Soldatos, Merlin C. Thomas
2005;26(iv):123
View Abstract View
Full Text (pdf)
The Relevance of Sweat Testing for the Diagnosis of Cystic Fibrosis
in the Genomic Era
Avantika Mishra, Ronda Greaves,John Massie
2005;26(iv):135
View Abstract View
Full Text (pdf)
Uncertainty of Measurement: What
it is and What it Should Be
Tony Badrick, Robert C. Hawkins, Susan R. Wilson and Peter E. Hickman.
2005;26(iv):155
View
Full Text (pdf)
Uncertainty of Measurement is Exactly That
(or the hitch-hikers pocket guide to the uncertainties of laboratory
results and their interpretation)
Graham H. White 2005;26(iv):159
View
Full Text (pdf)
Hepcidin - the Iron Regulatory
Hormone
Enrico Rossi 2005;26(iii):47
View
Full Text (pdf)
Metabolic Syndrome and Type 2 Diabetes:
The Hong Kong Perspective
Norman N Chan, Alice PS Kong,Juliana CN Chan
2005;26(iii):51
View Abstract View
Full Text (pdf)
Preparing the Biochemistry Laboratory
for the Next Outbreak:
Lessons from SARS in Singapore
Robert Hawkins
2005;26(iii):59
View Abstract
View
Full Text(pdf)
Recent Developments in the First
Detection of Hepatocellular Carcinoma
Joseph B. Lopez
2005;26(iii):65
View Abstract View
Full Text (pdf)
Chronic Kidney Disease and Automatic
Reporting of Estimated Glomerular Filtration Rate: A Position Statement
The Australasian Creatinine Consensus Working Group
2005;26(iii):81
View Abstract View
Full Text (pdf)
Managing Conflict of Interest:
sense and sensibility
Martin B Van Der Weyden and Mabel Chew
2005;26(ii):3
View Full Text (pdf)
The Evidence Based Medicine Approach to Diagnostic Testing:
Practicalities and Limitations
Robert C Hawkins
2005;26(ii):7
View Abstract
View Full Text (pdf)
Insulin and Insulin Resistance Gisela Wilcox
2005;26(ii):19
View Abstract View
Full Text (pdf)
Biochemical Assessment and Long-Term Monitoring
in Patients with Acromegaly: Statement from a Joint Consensus Conference
of The Growth Hormone Research Society and The Pituitary Society
Ee Mun Lim and Peter Pullan
2005;26(ii):41
View Full Text (pdf)
Standardised,
Metabolite-Specific Assays with Validated Decision Limits:
Utopian Ideal or Achievable Goal?
Paul Glendenning
2005;26(i):3
View Full Text (pdf)
HbA1c Standardisation
Destination – Global IFCC Standardisation
How, Why, Where and When
A Tortuous pathway From Kit Manufacturers via Inter laboratory Lyophilized
and Whole Blood Comparisons to Designated National Comparison Schemes
Ian Goodall
2005;26(i):5
View Abstract View
Full Text (pdf)
Vitamin D: A Hormone for All Seasons
- How Much is Enough?
Howard A Morris
2005;26(i):21
View Abstract
View
Full Text (pdf)
Improving the Measurement of 25-hydroxyvitamin
D
Andrew M Wootton
2005;26(i):33
View
Full Text (pdf)
Androgen Insufficiency in Ageing
Men: How is it Defined and Should it be Treated?
Penelope Coates
2005;26(i):37
View Full Text(pdf)
Are Routine Testosterone Assays Good Enough?
Sydney S Sacks
2005;26(i):37
View Full Text (pdf)

Supplement 2005
Proceedings
of the AACB's 43rd Annual Scientific Conference
Vol 25, 2004
Genetic Polymorphisms, Drug Metabolism and Drug
Concentrations
Gillian M Shenfield 2004;25(iv):203
View Full Text (pdf)
The Future of Laboratory Medicine:
Understanding the new Pressures
Mauro Panteghini 2004;25(iv):207
View Abstract
View
Full Text (pdf)
Uncertainty of Measurement in Quantitative Medical Testing:
A Laboratory Implementation Guide
Graham H White and Ian Farrance 2004;25(iv):207
View Full Text (pdf)
The Insulin-like Growth Factor System: Towards
Clinical Applications
Leon A Bach 2004;25(iii):155
View Abstract View
Full Text (pdf)
The Clinical Biochemistry of Obesity
Ken A Sikaris 2004;25(iii):165
View Abstract View
Full Text (pdf)
Clinical Penetrance of C282Y Homozygous HFE Haemochromatosis
Enrico Rossi and Gary P Jeffrey 2004;25(iii):183
View Abstract
View Full Text (pdf)
Subclinical Hypothyroidism: Subclinical Thyroid Disease: Scientific
Review and Guidelines for Diagnosis and Management. Reviewed by Melissa
Gillett 2004;25 (iii):191
View FullText (pdf)
Definition of Metabolic Syndrome: Report of the National Heart, Lung,
and Blood Institute/ American Heart Association Conference on Scientific
Issues Related to Definition
Reviewed by John Beilby 2004;25(iii):195
View Full Text (pdf)
The Case for Common Reference Intervals
Graham RD Jones, Antony Barker, Jill Tate, Chen-Fee Lim,
Ken Robertson 2004;25(ii):99
View Abstract View
Full Text (pdf)
Int erferences in Immunoassay
Jill Tate, Greg Ward 2004;25(ii):105
View Abstract
View Full Text (pdf)
Severe Acute Respiratory Syndrome:
Clinical and Laboratory Manifestations
Christopher W K Lam, Michael H M Chan, Chun K Wong
2004;25(ii):121
View Abstract
View Full Text (pdf)
The Laboratory Diagnosis of Severe Acute Respiratory Syndrome: Emerging
Laboratory Tests for an Emerging Pathogen
Susan E. Richardson, Raymond Tellier, James Mahony
2004;25(ii):133
View Abstract View
Full Text (pdf)
Molecular Epidemiology of the Coronavirus Associated with Severe Acute
Respiratory Syndrome: A Review of Data from The Chinese University of
Hong Kong
Stephen S.C. Chim, Y.M. Dennis Lo and members of The Chinese University
of Hong Kong Molecular SARS Research Group
2004;25(ii):143
View Abstract View
Full Text (pdf)
Diagnosis and Complications of Cushing's Syndrome: a Consensus Statement.
Reviewed by Chotoo Bhagat 2004;25 (ii):149
View Full Text (pdf)
A Glimpse at HDL-based Therapy for Atherosclerosis
Robert A Hegele 2004;25(i):3
View Abstract View
Full Text (pdf)
HDL Revisited: New Opportunities for Managing Dyslipoproteinaemia and
Cardiovascular Disease
Gerald F Watts, John R Burnett 2004;25(i):7
View Abstract View
Full Text (pdf)
The Vascular Implications of Post-prandial Lipoprotein Metabolism
David R Sullivan, David S Celermajer, David G Le Couteur, Christopher
W. K. Lam
2004;25(i):19
View Abstract
View Full Text(pdf)
Lipoprotein Kinetics in the Metabolic Syndrome: Pathophysiological
and Therapeutic Lessons from Stable Isotope Studies
Dick C. Chan, P Hugh R Barrett, Gerald F. Watts 2004;25(i):31
View Abstract View Full Text (pdf)
Familial Hypercholesterolaemia
A. David Marais 2004;25(i):49
View Abstract
View
Full Text (pdf)
Lipoprotein(a): Biology and Clinical Importance
Sally P. A. McCormick 2004;25(i):69
View Abstract
View Full Text (pdf)
A Practical Approach to Using Mice in Atherosclerosis Research
Stewart C. Whitman 2004;25(i):81
View Abstract
View Full Text (pdf)
Supplement 2004
Proceedings
of the 10th Asian Pacific Congress of Clinical Biochemistry in conjunction
with the AACB's 42nd Annual Scientific Conference
Vol 24, 2003
The Reporting of Cardiac Troponin
P Hickman et al. 2003;24(iv):99
View Full Text (Pdf)
Assessment of Thyroid Function: Towards an Integrated Laboratory-Clinical
Approach
J Stockigt 2003;24(iv):109
View Abstract View
Full Text (Pdf)
Results of an Innovative Education, Training
and Quality Assurance Program for Point-of-Care HbA1c Testing using
the Bayer DCA 2000 in Australian Aboriginal Community Controlled Health
Services
M Shephard and J Gill 2003;24(iv):123
View Abstract
View Full Text Pdf)
Comments on the Proposed National Guidelines for Analysis of Cerebrospinal
Fluid for Bilirubin in Suspected Subarachnoid Haemorrhage. Produced
by a working group of UK NEQAS for Immunochemistry and in conjunction
with the National Audit Group of the Association of Clinical Biochemists
A Chalmers 2003;24(iv):131
View Full Text (Pdf)
Guidelines for the Detection of Diabetes Mellitus
- Diagnostic Criteria and Rationale for Screening
H Schneider, J Shaw, P Zimmet 2003;24(iii):77
View Full Text (Pdf)
Quality Leadership and Quality Control
T Badrick 2003;24(iii):81
View Abstract View
Full Text(Pdf)
The National Kidney Foundation Guideline on Estimation of the Glomerular
Filtration Rate. Reviewed by Graham Jones and Ee-Mun Lim 2003;24(iii):95
View Full Text (Pdf)
Cyclosporin Therapeutic Drug Monitoring - An
Established Service Revisited
RG Morris 2003;24(ii):33
View Abstract View
Full Text(Pdf)
Magnesium Metabolism and its Disorders
R Swaminathan 2003;24(ii):47
View Abstract View
Full Text (Pdf)
Association of Clinical Pathologists (ACP) Best Practice No 165
Front line tests for the investigation of suspected Porphyria
E Rossi 2003;24(ii):67
View Full Text (Pdf)
Summary statement from a workshop on markers of inflammation and cardiovascular
disease: Applications to clinical and public health practice
J Beilby 2003; 24(ii):71
View Full Text (Pdf)
Electrospray Ionisation Mass spectrometry : Principles
and Clinical Applications
CS Ho, CWK Lam, MHM Chan, RCK Cheung, LK Law, LCW Lit, KF Ng, MWM Suen,
HL Tai
2003;24(i):3
View Abstract
View Full Text (Pdf)
Vitamin D Metabolism: New Concepts and Clinical
Implications
PH Anderson, BK May, HA Morris 2003;24(i):13
View Abstract View
Full Text (Pdf)
Summary statement from a workshop on asymptomatic
primary hyperparathyroidism:
A perspective for the 21st Century
P Glendenning 2003;24(i):27
View Full Text (Pdf)
Supplement 2003
Proceedings
of the AACB's 41st Annual Scientific Conference

Volume
23, 2002
Brain Natriuretic Peptide: its Function and Diagnostic Application
T Yandle, G Nicholls, M Richards 2002;23(i):3
Heavy Metal Poisoning: Clinical Significance and Laboratory Investigation
R Cheung, M Chan, C Ho , C Lam, E Law, L Lit, K Ng, H TaiI 2002;23(i):22
Analysing the Olympic Games: A Case Study Within the Anti-Doping Programme:
An Overview
R Kazlauskas 2002;23(ii):35
Circulating DNA in Plasma and Serum: Biological and Clinical Implications
Y Lui, Y (Dennis) Lo 2002;23(ii):52
40th Annual Scientific Conference of the AACB, Adelaide
2002;23(iii):70
Handling Common Laboratory Interferences
G Jones 2002;23(iv):105
Binge Drinking and Birth Defects: the Aetiological Importance of Zinc
and Metallothionein
L Carey, P Coyle, J Philcox, A Rofe 2002;23(iv):112

Volume 22, 2001
Renin and Aldosterone: Clinical Significance
and Laboratory Measurement
L Law, M Chan, R Cheung, C Ho, C Lam, L Lit, K Ng, H Tai
2001;22(i):3
Laboratory Investigation of Inherited Risk Factors for Venous Thrombosis
I Ramasamy 2001;22(i):6
Telomere and Telomerase: Useful Prognostic Factors and Targets for Cancer
Therapy?
C Leong, H Seow 2001;22(ii):39
The Evolving Clinical Role of Cardiac Troponins and new Acute Myocardial
Infarction Guidelines: Implications for the Clinical Laboratory
P Sheehan, S Vasikaran 2001; 22(ii): 52
39th Annual Scientific Conference of the AACB, Auckland
2001; 22(iii): 69
Evidence Based Laboratory Medicine
C Price 2001; 22(iv): 99
Postpartum Thyroid Dysfunction: a Case for Biochemical Screening
N Kent 2001; 22(iv): 110

Volume 21, 2000
Neurotransmitter Diseases
J Earl 2000;21(i):3
The new Genetics and Mitochondrial Respiratory Chain Disorders
J Christodoulou 2000;21(i):14
The Structure and Multifaceted Function of the Amyloid Precursor Protein
A Boyt, T Suzuki, E Hone, A Gnjec, R Martins 2000;21(i):22
The Human Genome Project
G Sutherland 2000;21(ii):45
The Role of Proteases and Antiproteases in Emphysema
R Walsh, E Cleary, G McLennan 2000;21(ii):51
Risk Stratification of Cardiac Troponin in Ischaemic and Non-Ischaemic
Cardiac Diseases and Procedures
A Wu 2000;21(iii):79
Cryoglobulins: Identification and Clinical Significance
L Lit, M Chan, R Cheung, C Ho, L Law, C Lam, K Ng, H Tai 2000;21(iii):89
Oestrogens and Breast Cancer
R El-Sadig, L Lai 2000;21(iii):93
38th Annual Scientific Conference of the AACB, Canberra
2000;21(iv):101
Volume 20, 1999
The
Growth Hormone-Insulin-Like Growth Factor Axis and Prostate Cancer
LK Chopin, AK Herrington 1999;20(i):3
Recent Advances in Iron Metabolism and Haemochromatosis
I Ramasamy, P Horn 1999;20(i):17
Clinical Use of Bone Resorption Markers
P Coates 1999;20(ii):39
Impaired Glucose Tolerance and the Metabolic Syundrome: Recent Advances
in Aetiopathogenesis, Diagnosis and Management
N Thomas 1999;20(ii):50
37th Annual Scientific Conference of the AACB, Melbourne
1999;20(iii):65
The Biology, Clinical Significance and Measurement of Lipoprotein(a)
J Tate 1999;20(iv):107
Identification of Cerebrospinal Fluid Markers in the Diagnosis of Alzheimer's
Disease
D Small, G Sverna, J Saez-Valero, S San Mok 1999;20(iv):123
Volume
19, 1998
Calcium Homeostasis
and Osteoporosis
PD O'Loughlin , HA Morris 1998;19(i):1
Drugs of abuse, analytical and clinical perspective in the 1990s
JH Lewis, L Dusci, P Hackett, JM Potter 1998;19(i):18
Apolipoproteins 8-100 and E:gene polymorphisms and their role in lipid
metabolism and coronary heart disease
CDS Mamotte 1998;19(ii):36
Parathyroid hormone-related protein
W Rankin, MHC Lam, TJ Martin 1998;19(ii):53
36th Annual Scientific Conference of the AACB, Brisbane
1998;19(iii):70
New Technology for the Clinical Laboratory
P Wilding 1998;19(iv):100
Zinc in Man
P Coyle, JC Philcox, AM Rofe 1998:19(iv):107
Leadership in Healthcare
A Preston, T Badrick, R Simons 1998;19(iv):118
Volume 18, 1997
Clinical Chemistry
and the New Assisted Reproductive Technologies
RJ Norman 1997;18(i):3
Obesity, part of the metabolic syndrome
ID Caterson 1997;18(i):11
Post prandial lipaemia, atherogenic lipoproteins and coronary artery
disease
SK Sethi 1997 18(i):22
Improving Laboratory Utilisation
Robert C Hawkins 1997;18(ii):35
Optical Sensors: Principals and Clinical Applications
Andrew St John 1997;18(ii):46
Mild to Moderate Hyperhomocysteinaemia: A Risk Factor for Vascular Disease
Samuel D Vasikaran, Frank Van Bockxmeer 1997;18(ii):55
35th Annual Scientific Conference of the AACB, Perth
1997;18(iii):79
Iron in Today's Laboratory
P Garcia-Webb 1997;18(iv):113
Erythropoiesis and Lineage Switching
P Tilbrook, J Williams, E Ingley, P Klinken 1997;18(iv):124
Autoimmune Thyroid Disease: Recent Advances in the Era of Cloned Autoantigens
B Yeap, P O'Leary, P Leedman 1997;18(iv):133
Volume 17, 1996
Oxidative Stress
and the Cell
P Vervaart, KR Knight 1996;17(i):3
Oestradiol, Bone Metabolism and Calcium Homeostasis
NA Sims, HA Morris 1996;17(i):17
Total Quality Management and its Implementation in Health Care Organisations
T Badrick 1996;17(ii):31
Clinical Interpretation of Lipoprotein Metabolism and its Role in Cardiovascular
Disease
D Sullivan 1996;17(ii):43
Prostate Specific Antigen
K Sikaris 1996;17(ii):50
34tH Annual Scientific Conference of the AACB, Darwin
1996;17(iii):69
Quality Specifications in Laboratory Medicine
CG Fraser 1996;17(iv):109
The Clinical, Biochemical and Molecular Pathology of Mitochondrial Disorders
J Christodoulou 1996;17(iv):115
Recent Insights into the Molecular Genetics of Thyroid Cancer
PJ Leedman 1996;17(iv):125
Volume 16, 1995
Markers of Bone
Resorption and their Application in Metabolic Bone Disease
GN Kent 1995;16(i):4
The New Human Genetics: Present Successes, Potential Perils
JA Witkowski 1995;16(i):12
The Physiology, Measurement and Pathology of Parathyroid Hormone
A St John 1995;16(ii):27
Cytokines: New Markers of Inflammation?
K Byron, K Botting, A Wootton 1995;16(ii):38
32nd Annual Scientific Conference of the AACB, Sydney
1995;16(iii):49
Commercialization of Laboratory Services
BE Statland 1996:16(iv):86
Insulin-like Growth Factors and Insulin-like Growth Factor Binding Protein-3
in the Circulation: Growth Regulators and Glucoregulators
RC Baxter 1996:16(iv):91
Capillary Electrophoresis - An Overview
MA Jenkins 1996:16(iv):98
CO-Oximetry - An Historical Review
PA Godsell 1996:16(iv):104
Volume
15, 1994
Antenatal Testing
with Pregnancy - Associated Markers
MJ Sinosich 1994;15(i):3
An Overview of Maternal Serum Alphafoetoprotein Screening
B Field 1994;15(i):9
The Role of Ultrasound in the Detection of Down syndrome
DA Ellwood 1994;15(i):11
Mid-Trimester Amniocentesis and First Trimester Chronic Villus Sampling:
A Clinical Review
A Boogert 1994;15(i):15
Prenatal Karyotyping for Trisomy 21
CG Roberts 1994;15(i):17
Trophoblast Cells in Maternal Blood: Prospects for Prenatal Diagnosis
WR Jones, CS Hawes, B Kalionis, UW Mueller, PA Brennan, H Suskin, A
Petropoulos,
SE Latham 1994;15(i):21
Molecular Techniques Used in Prenatal Diagnosis of Down Syndrome: Present
and Future
JB DE Haan, I Kola 1994;15(i):25
Liability for Unwanted Pregnancy
M Keaney1994;15(i):29
Ethical Judgements and Counselling Issues in Prenatal Diagnosis of Trisomy
21
G Brown 1994;15(i):31
Maternal Serum Screening for Down Syndrome: Are Maternal Age Criteria
Really Obsolete?
RG Ryall 1994;15(i):34
The Clinical Biochemist-Reviews: End of an Era
RAJ Conyers 1994;15(ii):43
The Molecular Biology of Lipoprotein Lipase Deficiency
W Davies 1994;15(ii):45
Chromatography for the Clinical Biochemist
J Lewis, D Sampson 1994;15(ii):56
Future Diagnostic Assays for Atherosclerosis
RT Dean 1994;15(ii):64
Quality Control in the Clinical Laboratory
R Bais, TD Geary 1994;15(ii):68
Lipoprotein (a) Standardisation within Australia and New Zealand
J Tate 1994;15(ii):74
Corrigenda 1990-1994 1994;15(ii):82
32nd Annual Scientific Conference of the AACB, Adelaide
1994;15(iii):85
A QC Planning Process for Selecting and Validating Statistical QC Procedures
JO Westgard 1994;15(iv):156
Laboratory Protocols for Metabolic Bone Disorders
HA Morris 1994;15(iv):165
The Epidemiology of Osteoporotic Fracture and its Causative Factors
EA Geelhoed, A Criddle, RL Prince 1994;15(iv):173
Living with Lead: An Australian Overview
P Coyle, MR Haywood, AM Rofe 1994;15(iv):179
Volume 14, 1993
Pathology Practice
- Managing in Chaos or Leading Change?
RAJ Conyers 1993;14(i):3
Internationally Competitive Public Health Care Systems: The Hospital
Chief Executive Officer's Perspective
WA Kricker 1993;14(i):6
Pathology and the Challenge of Funding Changes in Health
ED Wilson 1993;14(i):I3
Forces for Change in Pathology
RF Vining 1993;14(i):15
The Future for Hospital Pathology Departments: Unbundling and Competition
WA Kricker 1993;14(i):19
Resource Management in Private Pathology Laboratories
L Panaccio 1993;14(i):22
Management Accounting: Changing the Culture
DB Logan 1993;14(i):27
Cost Accounting, Quality Assurance, Ethics and Lawyers: An American
Perspective
AJ Pesce 1993;14(i):31
Usefulness of Laboratory Costing Information
TD O'Leary, MD Guerin 1993;14(i):33
Financial Management - The Role of Cost Accounting
CM Ericksen 1993;14(i):36
Output-based Hospital Funding and Pathology Laboratory Costing: Some
Basic Considerations, a Preliminary Glossary and Introduction to the
Literature
RAJ Conyers, MJ Arblaster, PS McKeon, JS Milsom, C Margetts, L Coulston
1993;14(i):38
A Model Quality System for Total Quality Management in the Pathology
Laboratory
L Burnett, M Mackay, G Costaganna, W Shaw 199;14(i):47
Clinical and Laboratory Applications of Molecular Biology
RJ Trent 1993;14(ii):56
Genetically Modified Organisms The Australian Debate
JW Stocker 1993;14(ii):62
Disorders of Steroidogenesis in Children and Adult Women
J Montalto 1993;14(ii):68
Steroid Action
JW Funder 1993;14(ii):77
Summary of Results from the Thirtieth Cycle of the RCPA-AACB General
Serum Chemistry Quality Assurance Program
LA Penberthy, A Loxton, LR Wyndham, AE Clague, LA Coulston, K Williams
1993;14(ii):83
The Clinical Biochemist as Information Scientist
L Lazarus 1993;14(iii):112
Clinical Significance Of Metallothionein: a Dealer In Heavy Metals
P Coyle, JC Philcox, AM Rofe 1993;14(iii):118
Electrodes (Electrochemical Sensors)
BA Dilena, RF Leonard (Bibliography) 1993;14(iii):126
Summary Of Results from the Sixteenth Cycle of the RCPA-AACB
Special Therapeutic Drugs and Antibiotics Quality Assurance Program
LA Penberthy, A Loxton, LE Wyndham, L Burnett, LA Coulston, K Williams
1993;14(iii):134
Summary of Results from the Third Cycle of the RCPA-AACB Neonatal Bilirubin
Quality Assurance Program
LA Penberthy, A Loxton, LE Wyndham, L Burnett, LA Coulston, K Williams
1993;14(iii):141
Proceedings of the XVth International Congress Of Clinical Chemistry,
31st Annual Conference of the AACB, 6th Asian-Pacific Congress of Clinical
Chemistry, Melbourne,
1993;14(iv):149
Volume 13, 1992
Alcohol Metabolism
and Its Effects
JB Whitfield 1992;13(i):4
The Immunoassay Revolution
MC Stuart 1992;13(i):14
Biosensors
CR Lowe, DC Cullen, E Gizeli, NJ Goddard, LD Gray-Stephens, P Maynard,
BFY Yon Hin 1992;13(i):22
Summary of Results from the Twenty-Sixth Cycle of the RCPA-AACB
General Serum Chemistry Quality Assurance Program
LA Penberthy, LR Wyndham, AE Clague, TD Geary, K Williams 1992;13(i):27
Lipoprotein(a): Biology, Clinical Utility and Measurement
B Campbell, J Tate, F Lepre, P Hickman 1992;13(ii):55
The Clinical Biochemistry of Aluminium
PW DI Sciascio, GF Carter 1992;13(ii):60
Policy on Reporting of Results from the RCPA-AACB General Serum Chemistry
Quality Assurance Program
LA Penberthy, LE Wyndham 1992;13(ii):78
Proceedings of the 30th Annual Scientific Conference of the AACB, Hobart,
1992;13(iii):83
The Clinical Biochemistry of Malignancy
P Pannall 1992;13(iv):142
Cancer Cachexia: Metabolic and Hormonal Changes in the Host
SM Bourgeois, AM Rofe, RAJ Conyers, P Coyle, R Bais 1992;13(iv):152
Faecal Occult Blood Tests: Choice, Usage and Clinical Applications
GP Young, DJB St John 1992;13(iv):161
Phase III of the Apolipoprotein A-I and B 'State of the Art' Survey
CDS Mamotte, JRL Masarei, AA Musk 1992;13(iv):168
Diagnosis of Porphyria - Recommended Methods for Peripheral Laboratories
D Blake, V Poulos, R Rossi 1992;13(S):S24
Volume 12, 1991
Creatine Kinase Isoforms
and Variants (Bibliography)
R Bais 1991;12(i):3
Biogenic Amines: Significance, Measurement and Clinical Applications
DN Pillai, JW Earl, MW Duncan, DC Sampson, N Potezny, GA Crawford, EDM
Gallery, PG Hassel
1991;12(i):14
How Well is Calcium Measured?
TD Geary 1991;12(i):22
Haem Biosynthetic Enzymes
V Poulous, D Blake, J Mcmanus, E Rossi 1991;12(ii):31
Strategies for Interpretation of Clinical Laboratory Data
HA Morris 1991;12(ii):34
Instrumental Monitoring of Quality
TD Geary 1991;12(ii):38
Proceedings of the 29th Annual Scientific Conference of the AACB, Perth
1991;12(iii):47
Micronutrients in Health and Disease: Dietary Components as Modulators
of the Physiological Response to Trauma and Disease
TF Hartley 1991;12(iv):120
The Physiological Biochemistry of the Vitamins A, E, K, B12 and Folate
TF Hartley 1991;12(iv):122
The Physiological Biochemistry and Antioxidant Activity of the Trace
Elements Copper, Manganese, Selenium and Zinc
IE DreostiI 1991; 12(iv): 127
Micronutrients in the Pathology of Human Disease
TF Hartley 1991;12(iv):130
The Use of Micronutrient Supplements in Health and Disease
TF Hartley 1991;12(iv):136
Volume 11, 1990
Acute Phase Proteins,
Physiology and Clinical Uses
JT Whicher 1990;11(i):4
Biochemical Markers and Susceptibility to Alcohol Dependence
JB Whitfield 1990;11(i):10
Results from the Twenty first Cycle of the RCPA-AACB General Serum Chemistry
Quality Assurance Program
LA Penberthy 1990;11(i):16
Results from Cycle 10, 1989 Australasian Urine Quality Assurance Program
LA Penberthy 1990;11(i):34
The Allergic Reaction: Mechanisms and Pathology
A Wootton 1990;11(ii):50
Spectrum of Allergic Disease
D Gillis 1990;11(ii):54
Laboratory Tests for Allergy
A Wootton 1990;11(ii):55
Clinical Use of In Vitro Allergy Testing Present and Future Directions
D Gillis 1990;11(ii):58
Digoxin-Like Immunoreactive Substances
DM Howarth, G Koumantakis, DC Sampson 1990;11(ii):59
Guidelines for the Assessment of Diagnostic Systems for use in Clinical
Biochemical Testing
TD O'Leary, TD Geary 1990;11(ii):68
Proceedings of the 2nd Joint Meeting of the AACB AND NZACB, Auckland,
New Zealand
1990;11(iii):83
Interference in Clinical Biochemistry: 'Exploring the Brain-to-Brain
Loop'
S Sykes, I Goodall 1990;11(iv):144
The Detection and Assessment of Interference in Clinical Biochemistry
Analysis
I Goodall, S Sykes 1990;11(iv):150
The Detection and Assessment of Drug Interference in Clinical Chemistry
I Goodall, S Sykes 1990;11(iv):160
Specificity and Cross-Reactivity in Immunoassays
S Sykes, I Goodall 1990;11(iv):165
Volume 10, 1989
Atherogenesis
W J Hensley 1989;10(i):5
Probing the Future: Hormones Affecting Blood Pressure
J Shine 1989;10(i):13
NMR in Clinical Biochemistry
SJ Berners-Price, WA Bubb, PW Kuchel 1989;10(i):17
Standards for Enzyme Determination Part 1
R Bais 1989;10(i):21
Clinical Assessment of Thyroid Function and In Vitro Thyroid Function
Test
H Smith 1989;10(ii):32
The Interpretation of Thyroid Function Tests in Thyroid and Non-Thyroid
Disorders
TJ Wilke 1989;10(ii):35
Theoretical and Practical Considerations in the Measurement of Free
Thyroxine
TJ Wilke 1989;10(ii):39
Iodine Deficiency Diseases
H Smith 1989;10(ii):42
Interference with the Laboratory Assessment of Thyroid Function
RG Symons 1989;10(ii):44
Probes and Diagnostics: A New Future for Clinical Biochemistry
N Kalsheker 1989;10(ii):50
Standards for Enzyme Determination Part 2
R Bais 1989;10(ii):55
Results from Cycle 8, 1988 Australasian Urine Quality Assurance Program
LA Penberthy 1989;10(ii):60
Summary of Results from the Eighteenth Cycle of the RCPA-AACB
General Serum Chemistry Quality Assurance Program
LA Penberthy 1989;10(ii):64
Proceedings of the 27th Annual Scientific Conference of the AACB, Gold
Coast
1989 10(iii):79
The Formation and Investigation of Urinary Calculi
RL Ryall 1989;10(iv):149
The Clinical Biochemistry of the Alcohol Abuser
PR Pannall 1989;10(iv):158
Serum Versus Plasma
I Farrance 1989;10(iv):166
Erratum: Results from Cycle 8, 1988 Australasian Urine Quality Assurance
Program
LA Penberthy 1989;10(iv):169
Specimen Collection, Calibration and Controls
RF Moran, AJ Crockett 1989;10(iv):170
Standards for Enzyme Determination
R Bais 1989;10(iv):175
Volume 9, 1988
The Clinical Enzymology
of Alkaline Phosphatase
DW Moss 1988;9(i):4
The Mathematical Determination of Reference Intervals (Bibliography)
R Bais, RAJ Conyers 1988;9(i):9
Results from Cycle 5, 1987 Australasian Urine Quality Assurance Programme
MDS Shephard, LA Penberthy 1988;9(i):15
Summary of Results from the Fourteenth Cycle of the RCPA-AACB
General Serum Chemistry Quality Assurance Programme
LA Penberthy 1988;9(i):20
Analytical Developments and their Consequences
TD Geary 1988;9(ii):36
Non-Centralised Laboratory Practice What Do They Want and What
Can We Offer?
MD Guerin 1988;9(ii):39
Serum Lactate Dehydrogenase Isoenzyme-1 and Acute Myocardial Infarction
(Bibliography)
J Beilby 1988 9(ii):42
Accuracy: A Discussion on the Relative Importance of Methods, Instruments,
Reagents and Standards
LA Penberthy 1988;9(ii):48
Creatinine Interferences
P Boyne 1988;9(ii):54
Proceedings of the 26th Annual Scientific Conference of the AACB, Sydney
1988;9(iii):63
Apolipoproteins A-1 and B: Measurement and Applications
JRL Masarei, GD Calvert, ED Janus 1988;9(iv):119
Essential Considerations in the Provision of Near-Patient Testing Facilities
V Marks 1988;9(iv):124
Measurement of Bilirubin (Bibliography)
E Bland 1988;9(iv):128
Results from Cycle 1, 1988 RCPA-AACB QAP Blood Gases Programme
LA Howe 1988;9(iv):133
Volume 8, 1987
Normal Values,
Reference Ranges and Decision Points
WJ Riley 1987;8(i):5
An Overview of Present and Future Ultrasensitive Non-Isotopic Immunoassay
Development
RP Ekins 1987;8(i):12
A Critical Assessment of Data from the 1986 Australian Urine Quality
Assurance Programme
MDS Shephard 1987;8(i):24
Summary of Results from the Eleventh Cycle of The RCPA-AACB General
Serum Chemistry Quality Assurance Programme
LA Penberthy 1987;8(i):30
History and Diagnosis Criteria of Diabetes Mellitus
I Farrance, P Garcia-Webb 1987;8(ii):48
Albuminuria in Diabetes
P Garcia-Webb 1987;8(ii):51
Plasma Glucose Methods, A Review
I Farrance 1987;8(ii):55
Recent Developments in Analytical Luminescence
MJ Whiting 1987;8(ii):69
Serum Fructosamine (Bibliography)
MJ Staley 1987;8(ii):74
"The Invalid Result Artefact or Interference"
TD Geary 1987;8(ii):79
Biochemical Methods for Diagnosis of Carcinoid Tumour: What Should We
Really Be Measuring?
D Sampson 1987;8(iii):87
Phospholipase A2 (Bibliography)
SR Langton 1987; 8(iii): 95
Assessment of Materials and Monitoring of Internal Quality Control
P Boyne 1987;8(iii):101
Proceedings of the 25th Annual Conference of the AACB, Adelaide
1987;8(iv):119
Volume 7, 1986
The Types, Causes and
Progress of Renal Disease
L Barratt 1986;7(i):4
Biochemical Investigation of Renal Disease
M Peake 1986;7(i):10
Clinical and Biochemical Aspects of Proteinuria
L Barratt, M Peake 1986;7(i):16
Laboratory Tests in Acute Viral Hepatitis
L Burnett, YE Cossart 1986;7(i):23
The Measurement of Angiotensin-Converting Enzyme (Bibliography)
J E Buttery 1986;7(i):30
Evaluation of instrumentation in clinical chemistry (1985)
RD Jennings 1986;7(i):33
A Users Guide to Statistics in Clinical Chemistry
LA Penberthy 1986;7(ii):39
Parathyroid Hormone (Bibliography)
A St John 1986;7(ii):48
Biochemical Tests in Alcohol Abuse (Bibliography)
JB Whitfield 1986;7(ii):53
Your Laboratory Reference Ranges and National Reference Calibrators
TD Geary 1986;7(ii):59
Proceedings of the 24th Annual Conference of the AACB, Hobart
1986;7(iii):71
Volume 6, 1985
Newborn Screening for
Inborn Errors of Metabolism and Related Disorders
ARD Brown 1985;6(i):3
Amniotic Fluid Phospholipid Estimations in the Prenatal Assessment of
Fetal Lung Maturity
AG Andrews 1985;6(i):14
Pathogenesis of Malignant Hypercalcaemia
TJ Martin, JD Zajac, KW Ng 1985;6(i):24
Silver Staining of Proteins (Bibliography)
R McLachlan, D Burns 1985;6(i):29
An Introduction to the Theory and Practice of Enzyme Assays
D Adams 1985;6(ii):39
Porphyrins and Porphyrias
D Blake, J McManus, S Ratnaike, D Campbell 1985;6(ii):50
Biochemical Methods of Phaeochromocytoma Diagnosis:
What Should We Really Be Measuring?
MW Duncan, GA Smythe 1985;6(ii):62
Risk Factors for Cardiovascular Disease (Bibliography)
JRL Masarei 1985;6(ii):71
The Use of Computers in the Clinical Laboratory 1984-1985
TD Geary 1985;6(ii):75
Proceedings of the 23rd Annual Conference of the AACB, Melbourne
1985;6(iii):83
Congenital Disease and the Biochemist
J Connelly 1985;6(iv):124
Alcohol Metabolism and Toxicity
RD Batt 1985;6(iv):135
The 1985 Australasian Programme for Quantitative Urine Analysis
MDS Shephard, LA Penberthy, RD Mazzachi 1985;6(iv):139
Summary of Results from the Eighth Cycle of the RCPA-AACB
General Serum Chemistry Quality Assurance Programme
LA Penberthy 1985;6(iv):146
Volume 5, 1984
Steroid Assays
and their Application in Steroid Disorders
J Montalto 1984;5(i):3
Ionized Calcium: Its Measurement and Physiology (Bibliography)
TF Hartley 1984;5(i):12
Decision Criteria for the Selection of Laboratory Methods and Instruments.
Scientific Education Seminar, 1983
TD Geary 1984;5(i):19
Tissue Hypoxia
RG Ryall 1984;5(ii):42
Neonatal Bilirubin Methodology
LR Watkinson 1984;5(ii):47
Urine Protein (Bibliography)
BA Dilena 1984;5(ii):54
Clinical Biochemical Tests in Psychiatry (Bibliography)
RW Pain, H Morris, M Prior, J Edwards, T Huber 1984;5(ii):59
Recommendations for the Calibration of the Measurement of Bilirubin
Neonatal Bilirubin Working Party 1984;5(ii):64
Proceedings of the 22nd Annual Scientific Conference of the AACB, Perth
1984;5(iii):71
Biochemical Tests in the Diagnosis of Chronic Pancreatic Insufficiency
DM Goldberg 1984;5(iv):110
Measurements of Disturbed Iron Metabolism
RG Ryall 1984;5(iv):122
Applications of Recombinant DNA Technology
A Morley 1984;5(iv):128
Information from Erythrocytes
RG Ryall 1984;5(iv):131
The 1984 Australasian Programme for Quantitative Urine Analysis
MDS Shephard, LA Penberthy, RD Mazzachi 1984;5(iv):137
Summary of Results from the Fifth Cycle of the
RCPA-AACB General Serum Chemistry Assurance Programme
LA Penberthy1984;5(iv):145
Volume
4, 1983
Ion-Selective Electrodes
H Fong 1983;4(i):4
Bile Acids
MJ Whiting 1983;4(i):14
Biochemists: Brush Up Your Bedside Manner
ML Wellby 1983;4(i):21
Bedside Clinical Biochemistry How Far and How Fast?
JB Whitfield 1983;4(i):24
Bedside Clinical Biochemistry: Some Caveats
AM Carrerra, CG Fraser 1983;4(i):27
Serum Ferritin and Malignancy (Bibliography)
P Boyne, S Slater 1983;4(i):29
Congenital Adrenal Hyperplasia
P Boyne, PM Stevenson 1983;4(ii):40
Standardisation of Enzyme Analysis: Finding of the Expert Panel on Enzymes
of the IFCC
M Horder 1983;4(ii):51
AIpha-1-Antitrypsin (Bibliography)
A Muir, B Biegler 1983;4(ii):56
The Collection, Preservation, Storage and Stability of Urine Specimens
for Routine Clinical Biochemical Analysis
MDS Shephard, RD Mazzachi 1983;4(ii):61
Proceedings of the 21st Annual Scientific Conference of the AACB, Sydney
1983;4(iii):71
The Clinical and Biochemical Profile of Severe Illness
PR Pannall 1983;4(iv):105
The Biochemical Tests of an Emergency Laboratory
DW Osborn 1983;4(iv):109
Parenteral Nutrition Principles, Practice and Biochemical Monitoring
P Pannall, DW Osborn 1983;4(iv):115
B-Cell Tumours - A Resource for Clinical Biochemistry
PM Dennis 1983;4(iv):123
Recent Advances in Photometric Detection Systems
HL Pardue 1983;4(iv):131
The 1983 Australasian Programme for Quantitative Urine Analysis
MDS Shephard, LA Penberthy, CG Fraser 1983;4(iv):136
Summary of Results from the Third Cycle of the
RCPA-AACB General Serum Chemistry Quality Assurance Programme
LA Penberthy 1983;4(iv):141
Volume 3, 1982
Data Reduction for
Immunoassay
P Compton 1982;3(i):4
Amylase (Bibliography)
R Bais 1982;3(i):16
Interference with Jaffe Creatinine Assays (Bibliography)
I Goodall 1982;3(i):20
Strategies for the Improvement of Clinical Biochemistry Tests
CG Fraser 1982;3(i):23
Chorionic Gonadotropin
DL Hay 1982;3(ii):35
Clinical Reasons for the Assay of Drugs in Body Fluids
DC Sampson, WJ Hensley 1982;3(ii):43
Creatine kinase-MB Isoenzyme (Bibliography)
SR Langton 1982;3(ii):46
Practical Guidelines for Laboratory Quality Control. Planning a Laboratory
Quality Control Programme
(Committee Report) 1982;3(ii) 52
Proceedings of the 20th Annual Scientific Conference of the AACB, Adelaide
1982;3(iii):63
An Overview of Dynamic Investigation of Endocrine Dysfunction
L Lazarus 1982;3(iv):99
Measurement of Somatomedins (Insulin-Like Growth Factors) By Radioligand
Assay
RC Baxter 1982;3(iv):104
Summary of Results from the First Cycle of the RCPA/AACB General Serum
Chemistry Quality Assurance Programme
LA Penberthy 1982;3(iv):111
Laboratory Requirements for Dynamic Testing of Endocrine Function
MC Stuart 1982; (iv):119
The 1982 Australasian Programme for Quantitative Urine Analysis
MDS Shephard, LA Penberthy, CG Fraser 1982;3(iv):128
Volume 2, 1981
The
Diagnosis of Abnormal Glucose Tolerance
(Working Party Report) 1981;2(i):4
Comparative Methodology of Glucose
I Farrance 1981;2(i):7
Glycosylated Haemoglobins and Blood Glucose Concentrations
RG Ryall 1981;2(i):13
Assay of Oxalate in Calculi and Body Fluids (Bibliography)
RD Mazzachi 1981;2(i):20
Guidelines For The Performance Of Clinical Biochemistry Tests Outside
Laboratories
(Committee Report) 1981;2(i):24
Antibodies as Diagnostic Reagents Part I. Antibody Production
JD Wetherall, IR Lee 1981;2(ii):32
Steroid Radioimmunoassay
RF Vining 1981;2(ii):39
The Role of a-Fetoprotein in the Prenatal Diagnosis of Fetal Neural
Tube Defects
DL Hay 1981;2(ii):50
Guidelines for Candidates preparing for the Membership Examination of
the Australian Association of Clinical Biochemists
(Committee Report) 1981;2(ii):54
Guidelines for a Course of Study for Candidates preparing for the Membership
Examination of the Australian Association of Clinical Biochemists
(Committee Report) 1981;2(ii):55
Renal Stones (Bibliography)
RC Bowyer 1981;2(ii):61
Procedures for checking the performance of samplers, dispensers and
diluters
(Committee Report) 1981;2(ii):64
Proceedings of the 19th Annual Conference of the AACB, Melbourne
1981;2(iii):71
The Reversal of T3: a Pathophysiologic Perspective of Thyroid Secretion
ML Wellby 1981;2(iv):107
Interaction of Drugs with Clinical Laboratory Tests
DS Young 1981;2(iv):113
A Comparison of Methods Used for Drug Analysis
DC Sampson 1981;2(iv):119
Internal Quality Control Decision Making
(Committee Report) 1981;2(iv):126
Volume 1, 1980
Approaches to the Study of Comparative
Methodology
I Farrance 1980;1(i):4
An Approach to the Clinical Biochemistry of Disease
PM Dennis 1980;1(i):1
0How to Pass Examinations: A Personal View in Good Technique in Clinical
Biochemistry Examinations
AM Bold 1980;1(i):17
Analytical Goals in Clinical Biochemistry (Bibliography)
CG Fraser 1980;1(i):23
Guidelines for the Evaluation of Clinical Laboratory Instrumentation
TD Geary 1980;1(i):26
Introductory Pharmacokinetics
LN Sansom 1980;1(ii):36
Therapeutic Drug Monitoring (Bibliography)
TD O'Leary, CS Hann, RK Penhall 1980;1(ii):46
Guidelines for the Selection and Evaluation of Analytical Methods
TD Geary 1980;1(ii):51
Proceedings of the 18th Annual Scientific Conference of the AACB, Sydney
1980;1(iii):63
Medical Acid-Base Chemistry: Past and Present
P Astrup 1980;1(iv):99
Clinical Chemistry at the Crossroads
P Astrup 1980;1(iv):103
An introduction to the Biochemistry and Pathophysiology of Lipids and
Lipoproteins
GD Calvert, P Barter 1980;1(iv):106
The Analysis of Plasma Cholesterol, Triglyceride and High-Density Lipoprotein
Cholesterol
NDH Balazs 1980;1(iv):116